Sort
30,917 grants matching “tumor microenvironment”
Defining Tumor Microenvironmental Mediators of Prostate Cancer Metastasis and Therapy Resistance
$575,652Paula Jill Hurley · Vanderbilt University Medical Center · R01 · FY2024 · CA
Advancing allogeneic CAR-iNKT for the treatment of solid tumors through comparative oncology
$575,647Nicola J Mason · University Of Pennsylvania · U01 · FY2023 · CA
The Role of CD3z ITAM (Immunoreceptor Tyrosine-Based Activation Motif) diversity in CAR T cell Force and Function
$575,619Matthew Bettini · University Of Utah · R01 · FY2024 · CA
Dual p300 and p53 reactivation in HPV+ head and neck cancer
$575,570Quintin Pan · Case Western Reserve University · R01 · FY2024 · DE
Phase II Study of ASTX727 in Patients with PRC2 loss Malignant Peripheral Nerve Sheath Tumor (MPNST)
$575,542Ping Chi · Sloan-Kettering Inst Can Research · R01 · FY2023 · FD
Phase II Study of ASTX727 in Patients with PRC2 loss Malignant Peripheral Nerve Sheath Tumor (MPNST)
$575,542Ping Chi · Sloan-Kettering Inst Can Research · R01 · FY2025 · FD
Translational Pathology Core
$575,479Sue Ellen Martin · University Of Southern California · P30 · FY2022 · CA
Activating Native Tumor Immunity with IL-33 Armored CARs
$575,420Yina Hsing Huang · Dartmouth College · R01 · FY2025 · CA
Reorienting the Glioblastoma Microenvironment to Respond to Immunotherapy
$575,374Mary Helen Barcellos-Hoff · University Of California, San Francisco · R01 · FY2022 · NS
Data Science Core
$575,358Ming Li · University Of Southern California · P30 · FY2025 · CA
Role of the stromal microenvironment in B-cell lymphoma progression and immune escape
$575,256Leandro C Cerchietti · Weill Medical Coll Of Cornell Univ · R01 · FY2020 · CA
A translational study of a synthetic lethality interaction of CD105 and androgen receptor signaling axis for castration-resistant prostate cancer patients
$575,242Neil A Bhowmick · Cedars-Sinai Medical Center · R01 · FY2025 · CA
Leveraging CD26high Meso-CAR T cells in patients with advanced pancreatic cancer
$575,241Gregory B. Lesinski · Emory University · R01 · FY2024 · CA
Translating Autoantibodies Into Chimeric Antigen Receptor-T cell Therapy for Small Cell Lung Cancer
$575,240Kristin J Lastwika · Fred Hutchinson Cancer Center · U01 · FY2022 · CA
Pathways that regulate basal and metastatic phenotypes in triple negative breast cancers
$575,197Teresa L Wood · Rbhs-New Jersey Medical School · R01 · FY2021 · CA
Toward Clinical Trial: AXL-STAT3 Targeting of Lung Tumor Microenvironments
$575,193Josephine A Taverna · University Of Texas Hlth Science Center · R01 · FY2025 · CA
CAREER: Engineering biomimetic environments to elucidate mechanisms of dormancy in brain metastatic breast cancer cells
$575,193Shreyas S Rao · University Of Alabama Tuscaloosa · · FY2018 · ENG
Myoepithelial cell differentiation defects in ductal carcinoma in situ (DCIS)
$575,191Kornelia Polyak · Dana-Farber Cancer Inst · U01 · FY2009 · CA
Interstitial Fluid Flow Regulates Glioma Cell Invasion
$575,131Jennifer M Munson · Virginia Polytechnic Inst And St Univ · R37 · FY2018 · CA
Reorienting the Glioblastoma Microenvironment to Respond to Immunotherapy
$575,119Mary Helen Barcellos-Hoff · University Of California, San Francisco · R01 · FY2023 · NS
IMAGING T CELLS BY POSITRON EMISSION TOMOGRAPHY
$575,114Laurence J.n. Cooper · University Of Tx Md Anderson Can Ctr · R01 · FY2013 · CA
Understanding and targeting bone marrow microenvironment in myelofibrosis
$575,051Lei Ding · Columbia University Health Sciences · R01 · FY2023 · HL
Understanding and targeting bone marrow microenvironment in myelofibrosis
$575,051Lei Ding · Columbia University Health Sciences · R01 · FY2021 · HL
Understanding and targeting bone marrow microenvironment in myelofibrosis
$575,051Lei Ding · Columbia University Health Sciences · R01 · FY2022 · HL
Metabolic Therapy of GBM guided by MRS of hyperpolarized 13C-pyruvate
$575,027Lawrence D Recht · Stanford University · R01 · FY2014 · CA